Decreased Serum Amyloid A1 as Potential Diagnostic Marker for Gastro-Entero-Pancreatic Neuroendocrine Neoplasms

被引:0
|
作者
Na, H. [1 ]
Qiyun, T. [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
关键词
exosomes; serum amyloid a1; circulating biomarkers; diagnosis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A12
引用
收藏
页码:12 / 12
页数:1
相关论文
共 50 条
  • [41] Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia
    Marasco, Matteo
    Magi, Ludovica
    Rogges, Evelina
    Dell'Unto, Elisabetta
    Rinzivillo, Maria
    Pilozzi, Emanuela
    Annibale, Bruno
    Panzuto, Francesco
    ENDOCRINE, 2023, 82 (02) : 435 - 441
  • [42] Factors Predicting Prognosis in Metastatic Grade 1 Gastro-entero-pancreatic Neuroendocrine Tumors
    Pandrowala, Saneya A.
    Kapoor, Deeksha
    Kunte, Aditya
    Chopde, Amit
    Puranik, Ameya
    Dev, Indraja Devidas
    Parghane, Rahul
    Basu, Sandip
    Ramaswamy, Anant
    Ostwal, Vikas
    Chaudhari, Vikram A.
    Bhandare, Manish S.
    Shrikhande, Shailesh V.
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (03) : 1220 - 1228
  • [43] A Role for Vitamin D in the Gastro-Entero-Pancreatic Neuroendocrine Neoplasms Outcome: Report on a Series from a Single Institute
    Massironi, S.
    Zilli, A.
    Bernasconi, S.
    Fanetti, I
    Cavalcoli, F.
    Ciafardini, C.
    Felicetta, I
    Conte, D.
    NEUROENDOCRINOLOGY, 2017, 105 : 89 - 89
  • [44] A ROLE FOR THE VITAMIN D IN GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS OUTCOME: REPORT ON A SERIES FROM A SINGLE INSTITUTE
    Massironi, S.
    Zilli, A.
    Bernasconi, S.
    Fanetti, I.
    Cavalcoli, F.
    Ciafardini, C.
    Felicetta, I.
    Conte, D.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E181 - E181
  • [45] Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system
    Arnold, Christian N.
    Sosnowski, Andrea
    Schmitt-Graeff, Annette
    Arnold, Rudolf
    Blum, Hubert E.
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (10) : 2157 - 2164
  • [46] Insurance-based Disparities in Gastro-Entero-Pancreatic Neuroendocrine Tumor Patients
    Baechle, Jordan J.
    Smith, Paula Marincola
    Idrees, Kamran
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2021, 32 (03) : 1199 - 1207
  • [47] Does biopsy reliably identify grade in gastro-entero-pancreatic neuroendocrine tumors?
    Grillo, F.
    Brisigotti, M. P.
    Albertelli, M.
    Rossi, C.
    Fiocca, R.
    Mastracci, L.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 145 - 145
  • [48] Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma
    Akira Ooki
    Hiroki Osumi
    Koshiro Fukuda
    Kensei Yamaguchi
    Cancer and Metastasis Reviews, 2023, 42 : 1021 - 1054
  • [49] Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma
    Ooki, Akira
    Osumi, Hiroki
    Fukuda, Koshiro
    Yamaguchi, Kensei
    CANCER AND METASTASIS REVIEWS, 2023, 42 (03) : 1021 - 1054
  • [50] Dose Escalation of Octreotide Acetate for Management of Gastro-entero-pancreatic Neuroendocrine Tumors
    Chadha, Manpreet
    Chadha, Krishdeep
    Lombardo, Jeffery
    Mashtare, Terry
    Wilding, Gregory
    Gibbs, John
    Kuvshinoff, Boris
    Litwin, Alan
    Raczyk, Cheryl
    Javle, Milind
    Iyer, Renuka
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S103 - S103